Healthcare conglomerate CVS Well being Company (NYSE: CVS) reported greater revenues and adjusted revenue for the primary quarter of 2025. The outcomes exceeded expectations.
March-quarter adjusted earnings rose sharply to $2.25 per share from $1.31 per share within the year-ago quarter and beat estimates. On a reported foundation, web earnings was $1.78 billion or $1.41 per share in Q1, in comparison with $1.11 billion or $0.88 per share within the prior-year quarter.
Revenues elevated to $94.6 billion within the first quarter from $88.4 billion in the identical interval final 12 months, surpassing estimates. The corporate raised its FY25 adjusted EPS steering vary to $6.00-6.20 from the sooner outlook of $5.75 to $6.00.
“As we purpose to be essentially the most trusted healthcare firm in America, we’re driving better care, worth, and repair from our built-in, industry-leading companies,” stated CVS CEO David Joyner.
